FIELD: medicine.
SUBSTANCE: invention relates to new compounds having anti-cancer activity and their application for the treatment of cancer and drug-resistant tumors, such as melanoma, metastatic melanoma, drug-resistant melanoma, prostate cancer and drug-resistant prostate cancer.
EFFECT: obtaining compounds for cancer treatment.
9 cl, 25 ex, 24 tbl, 38 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2581367C2 |
COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
COMPOUNDS FOR CANCER TREATMENT | 2009 |
|
RU2514427C2 |
COMPOUND FOR TREATING CANCER | 2014 |
|
RU2708247C2 |
PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
AZADECALINS CONDENSED WITH HETEROARYLKETONES - GLUCOCORTICOID RECEPTOR MODULATORS | 2013 |
|
RU2639867C2 |
PIPERIDINE DERIVATIVES AS GPR119 AGONISTS | 2013 |
|
RU2603346C2 |
COMPOUNDS FOR TREATMENT OF CANCER | 2015 |
|
RU2805949C2 |
PIPERAZINYL PYRIMIDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF | 2013 |
|
RU2608315C2 |
Authors
Dates
2021-12-15—Published
2011-08-24—Filed